Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cerebrolysin for acute ischemic stroke
IRCT138803272042N1Phase 3Completed
- Sponsor
- Shahid Beheshti University of Medical Sciences
- Start
- Aug 2009
- Modality
- Peptide-based Cancer Vaccines → Cancer Vaccines → Therapeutic Vaccines → Vaccines & Immunotherapeutics, Native Peptides → Peptides, Modified Peptides → Peptides
- Countries
- 1
01
Overview
Phase 3, single-arm trial of cerebrolysin in ischemic stroke and brain infarction, sponsored by Shahid Beheshti University of Medical Sciences. Started Aug 2009; status: completed.
02
Drugs
cerebrolysin
03
Conditions
ischemic strokebrain infarction
Beyond the preview
Go deeper on IRCT138803272042N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT138803272042N1.